Efficacy - PUPs

In previously untreated patients (PUPs) aged ≤ 4 years with severe haemophilia A, 89% of all treated bleeding episodes were successfully treated with one (74%) or two (15%) infusions of KOGENATE ® Bayer (n=1178 bleeds) 1

Bleed control in PUPs with KOGENATE® Bayer 1

 

Bleed control in PUPs from prospective studies

Data from non-comparative studies. No published head-to-head studies of KOGENATE® Bayer vs ReFacto® exist.

 

References

1. Kreuz W et al Thromb Haemost 2005;93:457-467
6. Courter SG and Bedrosian CL. Semin Hematol 2001;38(2)(Suppl 4):44-57

Produced by Bayer. This website is intended for HealthCare professionals.
Date of preparation: December 2010 UK.PH.HN.KOG.2010.250.16.4